PERSPECTA

News from every angle

Back to headlines

Castle Biosciences Chief Commercial Officer Divests Shares

Castle Biosciences Chief Commercial Officer Tobin W sold $51,190 worth of company stock, reflecting ongoing executive portfolio adjustments in the diagnostic testing industry.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.